HUMAN TUMOURS IN CORTISONE-TREATED MICE

[1] ALBRINK WS, 1953, CANCER RES, V13, P64

[2] BAKER B L, 1952, Bull Schweiz Akad Med Wiss, V8, P25

[3] BICHEL J, 1949, ACTA PATHOL MIC SC, V26, P319

[4] BITTNER JOHN J., 1931, AMER JOUR CANCER, V15-16, P2202

[5] BJORNEBOE M, 1951, J EXP MED, V93, P37, DOI 10.1084/jem.93.1.37

[6] BLOCK M, 1952, CANCER RES, V12, P250

[7] CAVALLERO C, 1951, ARCH INT PHARMACOD T, V86, P43

[8] CLEMMENSEN J, 1940, AM J CANCER, V38, P483

[9] CLEMMESEN J, 1938, INFLUENCE XRAD DEV I

[10] CORNMAN I, 1951, SCIENCE, V133, P37

[1] ALBRINK WS, 1953, CANCER RES, V13, P64

[2] BAKER B L, 1952, Bull Schweiz Akad Med Wiss, V8, P25

[3] BICHEL J, 1949, ACTA PATHOL MIC SC, V26, P319

[4] BITTNER JOHN J., 1931, AMER JOUR CANCER, V15-16, P2202

[5] BJORNEBOE M, 1951, J EXP MED, V93, P37, DOI 10.1084/jem.93.1.37

[6] BLOCK M, 1952, CANCER RES, V12, P250

[7] CAVALLERO C, 1951, ARCH INT PHARMACOD T, V86, P43

[8] CLEMMENSEN J, 1940, AM J CANCER, V38, P483

[9] CLEMMESEN J, 1938, INFLUENCE XRAD DEV I

[10] CORNMAN I, 1951, SCIENCE, V133, P37